Ravi Thadhani, M.D., M.P.H.

Ravi Thadhani is the chief academic officer of Mass General Brigham (MGB). He manages a roughly $2 billion research enterprise. He oversees several key system-wide departments at MGB, including human subjects affairs, the clinical trials office, research management, the MGB Biobank, and graduate medical education across MGB.

Thadhani managed a research laboratory for 25 years, with a focus on kidney disease and developing diagnostics and therapeutics for women with complications in pregnancy. He has published over 300 manuscripts and has been inducted into several honor societies. He is a standing member of FDA’s Cardio-Renal Division Advisory Panel. Thadhani has received several distinguished awards including the Harold Amos Faculty Diversity Award from Harvard Medical School, the Alumni Award of Merit from the Harvard T.H. Chan School of Public Health, and the John P. Peters Award from the American Society of Nephrology.

Thadhani received a bachelor’s degree from the University of Notre Dame, a medical degree from the University of Pennsylvania, and a master’s in public health from the Harvard T.H. Chan School of Public Health.

May 2021